Patent details

Basic Information

Publication number:

EP2598526

PCT Application Number:

US2011045995

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP117496125

PCT Publication Number:

WO2012016203

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CHIMERIC IL-1 RECEPTOR TYPE I AGONISTS AND ANTAGONISTS

French Title of Invention:

AGONISTES ET ANTAGONISTES CHIMERIQUES DU RECEPTEUR D'IL-1 TYPE I

German Title of Invention:

CHIMÄRE IL-1 REZEPTOR TYP I AGONISTEN UND ANTAGONISTEN

SPC Number:

Dates

Filing date:

29/07/2011

Grant date:

05/09/2018

EP Publication Date:

05/06/2013

PCT Publication Date:

02/02/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

05/09/2018

EP B1 Publication Date:

05/09/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

29/07/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

09/10/2020

 

 

Name:

Buzzard Pharmaceuticals AB

Address:

Karolinska Science Park, Fogdevreten 2, 17165, Solna, Sweden (SE)

History of Owners

From:

09/10/2020

To:

09/10/2020

Name:

Sesen Bio, Inc.

Address:

245 First Street, Suite 1800, Cambridge, Massachusetts 02142, United States (US)

From:

29/08/2018

To:

09/10/2020

Name:

Eleven Biotherapeutics, Inc.

Address:

215 First Street Suite 400, Cambridge, MA 02142, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

10/10/2018

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

KING, Bracken, M.

Address:

United States (US)

2

Name:

BARNES, Thomas, M.

Address:

United States (US)

3

Name:

HOU, Jinzhao

Address:

United States (US)

Priority

1

Priority Number:

368799 P

Priority Date:

29/07/2010

Priority Country:

United States (US)

2

Priority Number:

201161436184 P

Priority Date:

25/01/2011

Priority Country:

United States (US)

3

Priority Number:

201161436178 P

Priority Date:

25/01/2011

Priority Country:

United States (US)

4

Priority Number:

201161493967 P

Priority Date:

06/06/2011

Priority Country:

United States (US)

5

Priority Number:

201161493966 P

Priority Date:

06/06/2011

Priority Country:

United States (US)

Classification

IPC classification:

A61P 19/02; C07K 14/545;

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2020/12

Publication date:

02/11/2020

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

CO

Bulletin edition number:

2020/12

Publication date:

02/11/2020

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:

201836

Publication date:

05/09/2018

Description:

Grant (B1)

2

Issue number:

201840

Publication date:

03/10/2018

Description:

Application number/publication number of the divisional application (Art. 76) changed

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20200000325A

Date Registered:

09/10/2020

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Changement de nom et d'adresse

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Sesen Bio, Inc.

Address:

245 First Street, Suite 1800, Cambridge, Massachusetts 02142, United States (US)

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20200000326A

Date Registered:

09/10/2020

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Buzzard Pharmaceuticals AB

Address:

Karolinska Science Park, Fogdevreten 2, 17165, Solna, Sweden (SE)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

31/07/2025

Annual Fee Number:

15

Annual Fee Amount:

213 Euro

Expected Payer:

Last Annual Fee Payment Date:

26/07/2024

Last Annual Fee Paid Number:

14

Last Annual Fee Paid Amount:

198 Euro

Payer:

CLARIVATE IP SERVICES LIMITED

Filing date	Document type	Number of pages
20/10/2020	Outgoing Correspondence	1
09/10/2020	Request For Change	7
24/10/2018	Outgoing Correspondence	1
09/10/2020	Request For Change	7
20/10/2020	Outgoing Correspondence	1
10/10/2018	Power Of Attorney	1